Medical Device made Easy Podcast

easymedicaldevice

My name is Monir El Azzouzi and I am a Medical Device Expert specialized in Quality and Regulatory affairs. And on this podcast I will help you place compliant medical devices on the market. For that I will share with you my knowledge or the one of others through discussion or interviews. I will invite experts in the area to tell you what you can do or the challenges you may encounter. This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

  1. NC vs CAPA: Are You Opening the Wrong Records?

    2h ago

    NC vs CAPA: Are You Opening the Wrong Records?

    One of the most common sources of confusion in medical device Quality Management Systems is knowing when to open a Nonconformity (NC) and when to initiate a Corrective and Preventive Action (CAPA). Some organizations turn every issue into a CAPA, while others rarely open one at all. Both extremes can create challenges during audits and may indicate an immature quality system. In this episode of the Medical Device Made Easy Podcast, we explain the fundamental differences between NCs and CAPAs and explore real-life situations to help quality professionals make better decisions. A Nonconformity simply indicates that a requirement has not been met. A CAPA, however, is a structured process designed to investigate and eliminate the root cause of significant, recurring, or systemic issues. Through multiple scenarios, we discuss: When an isolated event should remain a simple NC. How trends and recurring problems justify CAPAs. Why a single event can trigger a CAPA when patient safety is involved. Whether a CAPA always requires a Nonconformity first. Alternative sources of CAPAs, including complaints, audits, PMS activities, PSUR reviews, PMCF activities, and management reviews. How auditors evaluate the maturity of a CAPA system. The three questions every quality professional should ask before deciding between an NC and a CAPA. The objective is not to open more CAPAs, nor to avoid them. The objective is to open the right CAPAs, based on risk, recurrence, and impact. Understanding this distinction is essential for building a robust and effective quality management system that supports compliance, patient safety, and continuous improvement. Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com  If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well. Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    25 min
  2. Best of „AI CE marking“

    Jun 11

    Best of „AI CE marking“

    Artificial intelligence is transforming healthcare, but developing an AI medical device is only part of the challenge. Manufacturers must also navigate certification requirements and maintain safety and performance throughout the entire product lifecycle. In two podcast episodes featuring Sandy Wright and Osman El-Koubani, we explore the journey from certifying LLM-driven medical devices to managing them after CE marking. Certifying LLM-Driven Medical Devices Large Language Models such as ChatGPT, Gemini, and Claude introduce new regulatory challenges. Unlike traditional software, these systems raise questions around predictability, validation, traceability, supplier management, and model updates. Topics discussed include: What defines an LLM-driven medical device Clinical evaluation strategies Demonstrating clinical benefit Using commercial AI models Supplier controls and external dependencies Significant changes and model updates Life After CE Marking Obtaining CE certification is not the end of the journey. AI medical devices require continuous monitoring once they reach the market. Manufacturers must address: Performance drift in real-world settings Collection and analysis of real-world data AI retraining and change management Predetermined Change Control Plans (PCCPs) Post-Market Surveillance (PMS) Continuous safety and performance evaluation AI Devices Require a Lifecycle Approach AI systems are dynamic technologies. Success depends not only on achieving certification, but also on maintaining control over performance, updates, and clinical safety throughout the product lifecycle. As regulations continue to evolve, manufacturers must combine robust development practices with proactive post-market monitoring to ensure long-term compliance and patient safety. Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com  If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well. Link Sandy LinkedIn: https://www.linkedin.com/in/wrightsandy/ Osman Linkedin: https://www.linkedin.com/in/osman-kan/ Scarlet Linkedin: https://www.linkedin.com/company/scarlet-comply/posts/?feedView=all&viewAsMember=true Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    27 min
  3. Medical Device News June 2026 Regulatory Update

    Jun 3

    Medical Device News June 2026 Regulatory Update

    Sponsor Medboard  Medboard: https://www.medboard.com/ EUROPE Europe Starts Regulating the Regulators - Implementing Regulation (EU) 2026/977: https://eur-lex.europa.eu/eli/reg_impl/2026/977/oj EUDAMED is mandatory - Panic is raising: https://health.ec.europa.eu/medical-devices-eudamed/overview_en Germany: https://www.bfarm.de/SharedDocs/Downloads/DE/Medizinprodukte/DMIDS-anleitung-anzeigepflichtige-mp-ivd.pdf?__blob=publicationFile Belgium: https://www.famhp.be/en/news/eudamed_clarifications_regarding_obligations_from_28_may_2026Portugal: https://www.infarmed.pt/web/infarmed/noticias/-/journal_content/56/15786/13092901 AI Medical Devices - Timeline changed for AI ACT: https://www.consilium.europa.eu/en/press/press-releases/2026/05/07/artificial-intelligence-council-and-parliament-agree-to-simplify-and-streamline-rules/ Germany guidance: https://www.bundesnetzagentur.de/DE/Fachthemen/Digitales/KI/5_Innovationen/_DL/Roadmap_Pilot.pdf?__blob=publicationFile&v=5 Spain new HTA - Royal Decree 415/2026: https://www.boe.es/boe/dias/2026/05/29/pdfs/BOE-A-2026-11587.pdf Denmark on languages - Reminder that there are requirements to follow: https://laegemiddelstyrelsen.dk/en/devices/registration-and-marketing/language-requirement/ UK MHRA regulatory advice meetings - Pay and ask what you want: https://www.gov.uk/guidance/medical-devices-ask-for-a-regulatory-advice-meeting-from-the-mhra Easy Medical Device solutions EasyIFU - electronic Instruction for Use: https://easyifu.com Smarteye - electronic Quality Management System: https://eqms-smarteye.com/ Rest of the World FDA reinforce Human Factors expectations - This is not nice to have: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/content-human-factors-information-medical-device-marketing-submissions Saudi Arabia bundling criteria - More products in a single application: https://www.sfda.gov.sa/sites/default/files/2026-05/MDS-G28.pdf Podcast Podcast Nostalgia - Re-listen latest podcast episodes: Episode 390 - How can a proper intended use save your device with Kanrandeep Badwal: https://podcast.easymedicaldevice.com/390-2/ Episode 391 - Feedback after 3 months of the new FDA QMSR is in place with Mathangi Srinivasan: https://podcast.easymedicaldevice.com/391-2/   Easy Medical Device Consulting activities (CE marking, Clinical Evaluation, QMS creation…) https://easymedicaldevice.com/services/mdr-ivdr-technical-documentation/ BOSS Program: Back Office Services eQMS: https://easymedicaldevice.com/smarteye-eqms/ EasyIFU: eIFU and Label creation: https://easymedicaldevice.com/easyifu/ Authorized Representative in EU, UK and Switzerland Market access all over the world: https://easymedicaldevice.com/services/market-access/ Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    28 min
  4. FEEDBACK AFTER 3 MONTHS OF THE NEW FDA QMSR IS IN PLACE 

    May 28

    FEEDBACK AFTER 3 MONTHS OF THE NEW FDA QMSR IS IN PLACE 

    The FDA’s new Quality Management System Regulation (QMSR) officially became effective on February 2nd, 2026, replacing the legacy Quality System Regulation (QSR) framework that had been in place for nearly 30 years. Three months later, the reality is becoming clear for many manufacturers:QMSR is far more than a simple regulatory update. It represents a complete transformation in how the FDA expects companies to manage quality, risk, design controls, manufacturing, supplier oversight, and post-market surveillance. From Siloed Quality to Lifecycle Thinking Under the old QSR framework, companies often treated quality activities separately: Design controls CAPA Manufacturing Supplier management Post-market surveillance QMSR changes this mindset entirely. FDA now expects manufacturers to demonstrate integrated, risk-based quality management across the entire product lifecycle. This means: Design changes must connect to manufacturing validation Supplier issues must feed into risk management Post-market surveillance must proactively identify trends Management reviews must show real decision-making Why Many Companies Were Not Ready A major misconception across the industry was believing that ISO 13485 certification automatically meant QMSR readiness. But manufacturers are now discovering major gaps: Incomplete Design History Files (DHF) Weak risk integration Poor documentation traceability Reactive PMS systems Limited management review evidence FDA inspections are already reflecting these expectations. Inspectors are requesting: Internal audit reports Supplier audit documentation Management review records Risk-based decision evidence This level of transparency is new for many organizations. Real-World Challenges Manufacturers Are Facing One of the biggest pain points is DHF restructuring. Companies with years of design changes are now being forced to reconstruct the logic behind historical decisions and organize fragmented information into a coherent, risk-based structure. Another major shift is Post-Market Surveillance. QMSR pushes manufacturers from reactive complaint handling toward proactive monitoring of known high-risk failure modes using trend analysis, registries, and real-world data. Management review processes are also under greater scrutiny.FDA now expects leadership teams to demonstrate how quality data drives actual strategic decisions. Best Practices for QMSR Transition Manufacturers preparing for QMSR should focus on: 1. Cross-functional collaboration Break down silos between QA, RA, Manufacturing, Design, and Supply Chain. 2. Documentation mapping Identify where critical design logic and risk decisions currently exist. 3. Continuous risk management Implement ongoing cross-functional risk review meetings. 4. Stronger internal audits Move beyond checklist auditing toward analytical risk-focused auditing. 5. Meaningful management reviews Use management review meetings to demonstrate active leadership involvement in quality decisions. Final Thoughts QMSR is fundamentally changing the FDA’s expectations. Companies that adapt early will build stronger systems, improve product quality, and reduce regulatory risk. Companies that delay may face: FDA 483 observations Warning Letters Product launch delays Increased remediation costs The transition to QMSR is not simply a compliance project. It is a complete redesign of how medical device companies manage quality. Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com  If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well. Link Mathangi Srinivasan linkedin: https://www.linkedin.com/in/mathangiks/ Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    51 min
  5. How can a proper Intended Use save your device?

    May 21

    How can a proper Intended Use save your device?

    A medical device’s intended use is not just a regulatory formality — it is the foundation of the entire product strategy. In this podcast episode, Monir El Azzouzi speaks with Karandeep Badwal about how intended use influences classification, clinical evaluation, risk management, labeling, and ultimately market access. The discussion explores why many companies underestimate the importance of intended use and how poorly written statements can create major downstream regulatory problems. From Software as a Medical Device (SaMD) to AI-driven products, the episode highlights real-world examples where unclear intended use created challenges during certification and compliance activities. The episode also provides practical guidance for manufacturers on: Defining a robust intended use statement Aligning intended use with clinical evidence and risk management Avoiding “labeling tricks” that may trigger regulatory scrutiny Building internal collaboration between regulatory, clinical, and product teams This is an essential discussion for MedTech startups, QA/RA professionals, and manufacturers navigating MDR, IVDR, FDA, or global regulatory pathways. Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com  If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well. Link karandeepbadwal linkedin: https://www.linkedin.com/in/karandeepbadwal/ qra-medical linkedin: https://www.linkedin.com/company/qra-medical/ Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    33 min
  6. Medical Device News May 2026 Regulatory Update

    May 13

    Medical Device News May 2026 Regulatory Update

    Sponsor: Medboard https://www.medboard.com/   Europe EUDAMED: It's Go Time -May 28th 2026 for New Products:  https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32024R1860&qid=1720686388639 https://health.ec.europa.eu/document/download/04ce2012-97df-4dd0-8a39-d4f6993b9e16_en?filename=md_eudamed_roadmap_en.pdf Brand new Notified Body Rules -Implementation regulation 2026/977 https://eur-lex.europa.eu/eli/reg_impl/2026/977/oj https://www.medtecheurope.org/resource-library/new-eu-rules-more-business-predictability-and-transparency-in-medtech-conformity-assessment/ EU MDR IVDR Simplification Proposal - 2 tracks https://www.europarl.europa.eu/RegData/docs_autres_institutions/commission_europeenne/com/2025/1023/COM_COM(2025)1023_EN.pdf EMA Breakthrough Medical Devices Pilot  - Just launched https://www.ema.europa.eu/en/news/new-pilot-support-development-breakthrough-medical-devices https://www.ema.europa.eu/en/documents/presentation/presentation-breakthrough-medical-devices-pilot-information-sessio_en.pdf MIR form update - Update your files or links: https://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance/pmsv-reporting-forms_en   Switzerland Swissdamed device Registration - July 1st is coming https://www.swissmedic.ch/swissmedic/en/home/medical-devices/medizinprodukte-datenbank/produktregistrierung.html Swissmedic's 2026 PMS Focus Campaign - Class Iia, Iib and III https://www.swissmedic.ch/swissmedic/en/home/medical-devices/market-surveillance-of-medical-devices/schwerpunktaktionen/info-ueberpruefung-dokumentation-zur-ueberwachung-nach-inverkehrbringen.html UK MHRA proposes indefinite CE Mark Recognition - Poll is closed https://www.gov.uk/government/consultations/medical-devices-regulations-targeted-consultation-on-the-indefinite-recognition-of-ce-marked-devices New UK Clinical Trials Framework -Live Since April 28th https://www.gov.uk/government/news/launch-of-clinical-trial-reforms New MHRA fees + Faster Incident Reporting -  Reminder to budget and update procedures. https://www.gov.uk/guidance/register-medical-devices-to-place-on-the-market#fees https://www.gov.uk/government/publications/medical-devices-post-market-surveillance-requirements/vigilance-reporting-requirements MHRA Medical Devices (Amendment) Regulations 2026 - Brand New, Your Input Needed https://www.gov.uk/government/news/mhra-invites-views-on-proposed-changes-to-medical-device-regulation   Events Medtech Summit - June 15-16, 2026 in Berlin, Germany https://informaconnect.com/medtech-summit European Medical Device Supplier Excellence Conference - June 9-11th, 2026 - Brussels, Belgium https://medicaldevicesupplierexcellence.com/   International USA — FDA Launches -  AI Platform HALO and Upgrades Elsa to 4.0 https://www.fda.gov/news-events/press-announcements/fda-expands-ai-capabilities-and-completes-data-platform-consolidation   Canada: Two changes happening —  Mandatory Digital Submissions + New AI/ML Device Guidance https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices/activities/announcements/mandatory-use-regulatory-enrolment-process-notice-to-industry.html https://www.canada.ca/content/dam/hc-sc/documents/services/drugs-health-products/medical-devices/application-information/guidance-documents/pre-market-guidance-machine-learning-enabled-medical-devices/pre-market-guidance-machine-learning-enabled-medical-devices.pdf   Podcast Podcast Nostalgia   Episode 384: AI Medical Devices: What Notified Bodies Really Look for (Camille Petri): https://podcast.easymedicaldevice.com/384-2/ Episode 385: The Fake QMS Problem: Why your ISO 13485 System will fail and Audit: https://podcast.easymedicaldevice.com/385-2/ Episode 386: Life after CE Marking: Why AI Medical Devices Need Continuous Monitoring (Osman El-Kouban): https://podcast.easymedicaldevice.com/386-2/ Episode 387: Master UDI-DI: The New Layer many Medtech Companies don't Understand (Hussam Mostafa):  https://podcast.easymedicaldevice.com/387-2/ Episode 388: Certifying LLM-Driven medical devices (Sandy Wright): https://podcast.easymedicaldevice.com/388-2/   Easy Medical Device Consulting activities (CE marking, Clinical Evaluation, QMS creation…) https://easymedicaldevice.com/services/mdr-ivdr-technical-documentation/ BOSS Program: Back Office Services eQMS: https://easymedicaldevice.com/smarteye-eqms/ EasyIFU: eIFU and Label creation: https://easymedicaldevice.com/easyifu/ Authorized Representative in EU, UK and Switzerland Market access all over the world: https://easymedicaldevice.com/services/market-access/   This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    48 min
  7. The Hidden Costs of UDI Mistakes in Medical Devices

    May 7

    The Hidden Costs of UDI Mistakes in Medical Devices

    Unique Device Identification (UDI) has become a central element of medical device compliance worldwide. From EUDAMED in Europe to FDA databases in the United States, regulators increasingly rely on accurate UDI data to improve traceability and patient safety. But many manufacturers underestimate one important reality: 👉 A small UDI mistake can become extremely expensive. Why UDI Accuracy Matters UDI is not simply a number placed on a label.It is a structured identification system connected to: • Device traceability• Regulatory databases• Market surveillance• Recalls• Post-market monitoring When UDI data is incorrect or incomplete, the impact can quickly spread across the entire quality and regulatory system. The Real Risks of Incorrect UDI Data An incorrectly calculated or poorly structured UDI can lead to: Product Recalls If products cannot be correctly identified, companies may need to perform recalls or field actions. Database Errors Incorrect submissions to EUDAMED or FDA databases may prevent customers and authorities from accessing accurate device information. Traceability Gaps Without proper identification, tracking affected products becomes difficult during complaints or vigilance activities. Financial Costs Fixing UDI errors after commercialization often requires:• Relabeling• Database corrections• Regulatory updates• Internal investigations All of these consume significant time and resources. Why Many Companies Struggle UDI implementation often requires coordination between:• Regulatory Affairs• Quality• Supply Chain• IT• Manufacturing Many organizations discover inconsistencies in:• Device families• Packaging hierarchies• Certificates• Product configurations Without strong governance, errors become inevitable. Best Practices to Avoid UDI Problems Manufacturers should: ✔ Validate UDI structures early✔ Review regulatory guidance carefully✔ Audit device data regularly✔ Test database submissions before launch✔ Ensure cross-functional ownership of UDI data Final Thought UDI mistakes are rarely “small” problems. In MedTech, inaccurate identification can affect compliance, operational efficiency, and ultimately patient safety. Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com  If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well. Link       Sandy LinkedIn: https://www.linkedin.com/in/wrightsandy/ Scarlet Linkedin: https://www.linkedin.com/company/scarlet-comply/posts/?feedView=all&viewAsMember=true Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    43 min
  8. Master UDI-DI: The New Layer Many MedTech Companies Don’t Understand

    Apr 30

    Master UDI-DI: The New Layer Many MedTech Companies Don’t Understand

    The implementation of Unique Device Identification (UDI) has already transformed regulatory compliance in the medical device industry. Now, Europe is introducing an additional layer: Master UDI-DI — adding both structure and complexity to the system. Understanding the UDI Structure To fully understand Master UDI-DI, it’s important to distinguish between the different levels: • UDI-DI → Identifies a specific device• Basic UDI-DI → Groups devices with the same intended purpose and characteristics• Master UDI-DI → Applies to highly individualized devices with specific design parameters This new layer aims to better manage products with high variability. Why Master UDI-DI Was Introduced For certain devices — such as spectacle frames, lenses, and other customizable products — the number of variations can become overwhelming. Master UDI-DI helps:• Reduce the number of identifiers required• Improve traceability• Simplify product grouping• Enhance recall efficiency Key Benefits Despite its complexity, Master UDI-DI brings several advantages: ✔ Better organization of device data✔ Improved market surveillance✔ Faster identification during recalls✔ Stronger protection against counterfeit products Challenges for Manufacturers However, the implementation is not without challenges: • Increased data requirements• Risk of incorrect UDI assignment• Need for cross-functional coordination• Integration with EUDAMED As highlighted in the discussion, errors in UDI can be costly — including recalls and data inconsistencies. Timeline and Urgency While the labeling deadline is set for November 2028, manufacturers should not wait. EUDAMED requirements are already active, and preparation takes time. 👉 Early implementation reduces risk, cost, and operational pressure. Best Practices To ensure compliance, manufacturers should: • Study MDCG guidance documents• Validate data before submission• Use tools for UDI calculation• Involve project managers and cross-functional teams• Seek expert support when needed Who is Al Hajj Sam Mostafa?  Al Hajj Sam Mostafa is founder and CEO of UDI Experts. He has nearly 10 years of UDI experience, in which he leads and provides his premiere UDI solutions to MedTech organizations. One of his prestige clients is of the Magnificent Seven (Big Tech) companies. UDI Experts continuously strives to offer their clients the best UDI services for the best prices. Their global services include medical device data collection, data registration, UDI label creation and UDI label support, UDI printing IQ/OQ/PQ, and much more.  Who is Monir El Azzouzi?  Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.  Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more.  If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com  If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well. Link Website: www.udiexperts.com Business LinkedIn: www.linkedin.com/in/udi-experts-600138189            Personal LinkedIn: www.linkedin.com/in/al-hajj-sam-m-03b69612 YouTube UDI Video for Dawa Medical  (below) Import IQ: Episode 5 Understanding the UDI with Hussam Mustafa  UDI Experts YouTube Channel: www.youtube.com/@UDIExperts-o3z Social Media to follow Monir El Azzouzi Linkedin: https://linkedin.com/in/melazzouzi Twitter: https://twitter.com/elazzouzim Pinterest: https://www.pinterest.com/easymedicaldevice Instagram: https://www.instagram.com/easymedicaldevice This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

    33 min
4.8
out of 5
20 Ratings

About

My name is Monir El Azzouzi and I am a Medical Device Expert specialized in Quality and Regulatory affairs. And on this podcast I will help you place compliant medical devices on the market. For that I will share with you my knowledge or the one of others through discussion or interviews. I will invite experts in the area to tell you what you can do or the challenges you may encounter. This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.

You Might Also Like